RTX vs SNOA · P/E 36, rev $88.60B vs rev $19.5M
RTX Corporation (RTX) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the RTX and SNOA stock pages for the full models.
Not investment advice.